Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation
Huang‐Ju Tu(Taipei Medical University), Wei‐Chun HuangFu(Taipei Medical University)
Cited by 7
Related Papers
A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo
|Frontiers in Pharmacology|2018|31
Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity
|Journal of Food and Drug Analysis|2023|30
Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo
|Scientific Reports|2017|5